CombinatoRx, Inc.
10Patents
1Active
10Granted
32Portfolio score
Filing activity: Nov 6, 2000 → Jun 30, 2005 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6693125B2 | Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders | Human Necessities | 65 | Expired |
| US6897206B2 | Combinations for the treatment of inflammatory disorders | Physics | 58 | Expired |
| US6569853B1 | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders | Human Necessities | 48 | Expired |
| US7795310B2 | Methods and reagents for the treatment of metabolic disorders | Human Necessities | 10 | Expired |
| US6846816B2 | Combinations of drugs for the treatment of neoplastic disorders | Human Necessities | 10 | Expired |
| US6955815B2 | Combinations for the treatment of inflammatory disorders | Physics | 5 | Expired |
| US7253155B2 | Combinations for the treatment of immunoinflammatory disorders | Human Necessities | 4 | Expired |
| US7335371B2 | Combinations for the treatment of inflammatory disorders | Physics | 4 | Expired |
| US7148216B2 | Combinations of drugs for the treatment of neoplastic disorders | Human Necessities | 3 | Expired |
| US7709495B2 | Methods and reagents for the treatment of inflammatory disorders | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.